Performance and Clinical Impact of Radiomics and 3D-CNN Models for the Diagnosis of Neurodegenerative Parkinsonian Syndromes on 18F-FDOPA PET.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
06 Aug 2024
Historique:
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: aheadofprint

Résumé

The aim of this study was to compare the performance and added clinical value of a semiautomated radiomics model and an automated 3-dimensinal convolutional neural network (3D-CNN) model for diagnosing neurodegenerative parkinsonian syndromes on 18F-FDOPA PET images. This 2-center retrospective study included 687 patients with motor symptoms consistent with parkinsonian syndrome. All patients underwent 18F-FDOPA brain PET scans, acquired on 3 PET systems from 2 different hospitals, and classified as pathological or nonpathological (by an expert nuclear physician). Artificial intelligence models were trained to replicate this medical expert's classification using 2 pipelines. The radiomics pipeline was semiautomated and involved manually segmenting the bilateral caudate and putamen nuclei; 43 radiomic features were extracted and combined using the support vector machine method. The deep learning pipeline was fully automatic and used a 3D-CNN model. Both models were trained on 417 patients and tested on an internal (n = 100) and an external (n = 170) test set. The final models' performance was evaluated using balanced accuracy and compared with that of a junior medical expert and nonexpert nuclear physician. On the internal test set, the 3D-CNN model outperformed the radiomic model with a balanced accuracy of 99% (vs 96%). It led to diagnostic performance similar to that of a junior medical expert (only 1 in 100 patients misclassified by both). On the external test set from a less experienced hospital, the 3D-CNN model allowed physicians to correctly reclassify the diagnosis of 10 out 170 patients (6%). The developed 3D-CNN model can automatically diagnose neurodegenerative parkinsonian syndromes, also reducing diagnostic errors by 6% in less-experienced hospitals.

Identifiants

pubmed: 39104036
doi: 10.1097/RLU.0000000000005392
pii: 00003072-990000000-01242
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: This work has been supported by the French government, through the 3IA Côte d’Azur Investments in the Future project managed by the National Research Agency (ANR) with the reference number ANR-19-P3IA-0002. The authors have no relevant conflict of interests to disclose.

Références

Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591–1601.
Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain. 1990;113:1539–1552.
Morbelli S, Esposito G, Arbizu J, et al. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020;47:1885–1912.
Darcourt J, Schiazza A, Sapin N, et al. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging. 2014;58:355–365.
Nioche C, Orlhac F, Boughdad S, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–4789.
Zwanenburg A, Vallières M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328–338.
Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest. 2008;68:77–80.
McInnes L, Healy J, Melville J. Umap: uniform manifold approximation and projection for dimension reduction. arXiv. 2018;1802.03426.
Selvaraju RR, Cogswell M, Das A, et al. Grad-cam: visual explanations from deep networks via gradient-based localization. Proceedings of the IEEE International Conference on Computer Vision. 2017;618–626.
Piccardo A, Cappuccio R, Bottoni G, et al. The role of the deep convolutional neural network as an aid to interpreting brain [18F] DOPA PET/CT in the diagnosis of Parkinson’s disease. Eur Radiol. 2021;31:7003–7011.
Magesh PR, Myloth RD, Tom RJ. An explainable machine learning model for early detection of Parkinson's disease using LIME on DaTSCAN imagery. Comput Biol Med. 2020;126:104041.
Comte V, Schmutz H, Chardin D, et al. Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT. Eur J Nucl Med Mol Imaging. 2022;49:3787–3796.

Auteurs

Thi Khuyen Le (TK)

From the Université Côte D'Azur, CNRS, Inserm, iBV, Nice, France.

Jacques Darcourt (J)

Department of Nuclear Medicine, Centre Antoine Lacassagne, UCA, Nice, France.

Micheline Razzouk-Cadet (M)

Department of Nuclear Medicine, CHU de Nice, UCA, Nice, France.

Anne-Capucine Rollet (AC)

Department of Nuclear Medicine, Centre Antoine Lacassagne, UCA, Nice, France.

Fanny Orlhac (F)

Laboratory of Translational Imaging in Oncology (LITO-U1288), Curie Institute, Inserm, PSL University, Orsay, France.

Classifications MeSH